Products & Services target the healthcare provider as a primary distribution channel to the patient. Practitioners receive scientific information, medical education, training and ongoing support on products and services from Verséa in addition to incremental practice revenue Verséa products generate. The combination of education and revenue generating offerings differentiates and drives loyalty with Verséa!

The Verséa R&D team includes 25+ leading physicians and researchers each regarded as national and/or global clinical experts and spokespersons Ongoing discovery, IP development and R&D is viewed as the cornerstone for long-term growth of the company and primary differentiator from others in our market segment. In this regard, Verséa is committed to its R&D program through self-funding, pursuit of grant funding from agencies including the National Institute of Health (NIH) and more importantly the publication of our data. The Diagnostics division has formed partnerships granting access to the highest quality testing solutions needed by healthcare providers worldwide. Our advisors are involved in the conduct of ongoing multi-site studies throughout the country in private practices.

The foundation of our pharmaceutical division is a novel drug discovery platform  with the ability to efficiently screen thousands of compounds annually saving millions in failed studies and trials. This platform creates a scientific data set for all pipeline assets emerging from the platform. The Verséa medical hemp products currently utilize proprietary technology, processes, and materials to provide 4.4X greater bioavailability and absorption levels. Our diagnostics division supplies rapid point of care and lab-based testing solutions that include infectious disease, woman’s health and drugs of abuse screening kits. All tests have been FDA approved or granted Emergency Use Authorization (EUA) by the FDA.